ArticleWorld journal of emergency medicine2026
Emergency transfusion of uncross-matched O-type red blood cells in patients with severe pelvic fracture: a multi-center propensity score-weighted analysis.
Article in World journal of emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe transfusion of uncross-matched O-type red blood cells (URBCs) is the global standard of care for emergency resuscitation in trauma. However, its application in China remains limited due to concerns over safety and resource availability. This study aimed to evaluate the clinical efficacy and safety of URBCs in patients with severe pelvic fractures.
methodsIn this multicenter, retrospective cohort study (2019-2023), patients with severe pelvic fractures (Abbreviated Injury Scale [AIS]≥3) transfused within 24 h of admission were stratified into the URBC and non-URBC groups. Propensity score overlap weighting (PSOW) was used to address confounding factors. The primary outcome was 30-day in-hospital mortality. Secondary outcomes included length of stay (LOS), 24-hour blood product consumption, and in-hospital complications.
resultsA total of 526 patients were included (URBC group,
conclusionEarly administration of URBCs for severe pelvic fractures is safe. While not associated with increased mortality or hemolytic transfusion reactions, early use of URBCs was linked to a significant reduction in coagulation-related blood product consumption. This study provides evidence supporting the implementation of URBC within resource-constrained trauma setting to improve resuscitation efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.